Pharmacokinetics of bevacizumab in haemodialysis

被引：1
|
作者：
Garnier-Viougeat, Nathalie [1 ]
Rixe, Olivier
Paintaud, Gilles
Ternant, David
Degenne, Danielle
Mouawad, Roger
Deray, Gilbert
Izzedine, Hassane
机构：
[1] Hop La Pitie Salpetriere, Dept Clin Oncol, Paris, France
[2] Hop La Pitie Salpetriere, Dept Nephrol, Paris, France
[3] Univ Tours, EA 3853, Tours, France
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2007年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：975 / 975
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetics of dabrafenib in a patient with metastatic melanoma undergoing haemodialysis
    Park, John J.
    Boddy, Alan V.
    Liu, Xiaoman
    Harris, David
    Lee, Vincent
    Kefford, Richard F.
    Carlino, Matteo S.
    PIGMENT CELL & MELANOMA RESEARCH, 2017, 30 (01) : 68 - 71
  • [32] Pharmacokinetics of nelfinavir during haemodialysis in a patient with HIV infection
    Armbruster, C
    Vorbach, H
    El Menyawi, I
    Meisl, FT
    Neumann, I
    AIDS, 2000, 14 (01) : 99 - 101
  • [33] Pharmacokinetics of polymyxin B in patients on continuous venovenous haemodialysis
    Sandri, Ana M.
    Landersdorfer, Cornelia B.
    Jacob, Jovan
    Boniatti, Marcio M.
    Dalarosa, Micheline G.
    Falci, Diego R.
    Behle, Taina F.
    Saitovitch, David
    Wang, Jiping
    Forrest, Alan
    Nation, Roger L.
    Zavascki, Alexandre P.
    Li, Jian
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (03) : 674 - 677
  • [34] Effect of Impaired Renal Function and Haemodialysis on the Pharmacokinetics of Aprepitant
    Arthur J. Bergman
    Thomas Marbury
    Trisha Fosbinder
    Suzanne Swan
    Lisa Hickey
    Thomas E. Bradstreet
    John Busillo
    Kevin J. Petty
    Kala-Jyoti Viswanathan Aiyer
    Marvin Constanzer
    Su-Er W. Huskey
    Anup Majumdar
    Clinical Pharmacokinetics, 2005, 44 : 637 - 647
  • [35] Pharmacokinetics of intravitreal bevacizumab (Avastin (R)) in rabbits
    Sinapis, Christos I.
    Routsias, John G.
    Sinapis, Angelos I.
    Sinapis, Dimitrios I.
    Agrogiannis, George D.
    Pantopoulou, Alkistis
    Theocharis, Stamatis E.
    Baltatzis, Stefanos
    Patsouris, Efstratios
    Perrea, Despoina
    CLINICAL OPHTHALMOLOGY, 2011, 5 : 697 - 704
  • [36] Clinical pharmacokinetics of bevacizumab in patients with solid tumors
    Jian-Feng Lu
    Rene Bruno
    Steve Eppler
    William Novotny
    Bert Lum
    Jacques Gaudreault
    Cancer Chemotherapy and Pharmacology, 2008, 62 : 779 - 786
  • [37] Pharmacokinetics of Intravitreally Injected Bevacizumab in Vitrectomized Eyes
    Ahn, Jeeyun
    Kim, Hyuncheol
    Woo, Se Joon
    Park, Ji Hyun
    Park, Sunyoung
    Hwang, Duck Jin
    Park, Kyu Hyung
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 29 (07) : 612 - 618
  • [38] Clinical pharmacokinetics of bevacizumab in patients with solid tumors
    Lu, Jian-Feng
    Bruno, Rene
    Eppler, Steve
    Novotny, William
    Lum, Bert
    Gaudreault, Jacques
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2008, 62 (05) : 779 - 786
  • [39] Citalopram pharmacokinetics in patients with chronic renal failure and the effect of haemodialysis
    Olav Spigset
    Staffan Hägg
    Bernd Stegmayr
    Rune Dahlqvist
    European Journal of Clinical Pharmacology, 2000, 56 : 699 - 703
  • [40] Telavancin pharmacokinetics in patients with chronic kidney disease receiving haemodialysis
    Gharibian, Katherine N.
    Lewis, Susan J.
    Heung, Michael
    Segal, Jonathan H.
    Salama, Noha N.
    Mueller, Bruce A.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (01) : 174 - 180
12345